International Translational Research Section

Mission & Goal

Head
Kazuki Sudo, M.D., Ph.D.

The International Translational Research (TR) Section makes use of the human resources and infrastructure of the National Cancer Center to promote international translational research.

One of the main activities is to promote research by improving the infrastructure for translational research. We will also monitor the situation of activities and projects researchers are involved and the updates from regulatory authorities in each country and build a strong network with them. In addition, we will contribute to the promotion of international translational research based on the business development strategies of the industry as well as promoting ancillary research on international therapeutic development. 

Member

Manager

Kazuki Sudo

Staff

Shinji Kosaka
Yuki Kojima
Sho Shiino
Yutaka Yoshida
Keisuke Watanabe
Shu Yazaki
Momoko Tokura

 Activity (Introduction of the project)

■A-TRAIN
Prospective sample analysis study of circulating tumor DNA (ctDNA) in solid tumors with metastatic and/or recurrent lesions. We will conduct this project together with several Asian countries.

■MASTER KEY ASIA
Platform trial to promote the development of international rare cancer treatment. We are mainly in charge of genomics research.

■TEAL
Phase II investigator-initiated study in cervical cancer using an investigational product not approved in Asia, including Japan. We promote screening and ancillary research.